{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:10:40Z","timestamp":1791562240339,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013733","name":"Ipsen Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014382","name":"Ipsen Pharma SAS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.apmr.2024.10.017","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T23:20:10Z","timestamp":1732058410000},"page":"894-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-6424","authenticated-orcid":false,"given":"Alberto","family":"Esquenazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Zorowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Beneteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Maisonobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hannes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Jacinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 Suppl 2","key":"10.1016\/j.apmr.2024.10.017_bib0001","first-page":"S13","article-title":"Toward an epidemiology of poststroke spasticity","volume":"80","author":"Wissel","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2024.10.017_bib0002","first-page":"111","article-title":"Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review","volume":"10","author":"Martin","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.apmr.2024.10.017_bib0003","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1532-5415.2003.51104.x","article-title":"Physical performance measures in the clinical setting","volume":"51","author":"Studenski","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.apmr.2024.10.017_bib0004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/gerona\/glv126","article-title":"Gait speed predicts incident disability: a pooled analysis","volume":"71","author":"Perera","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.apmr.2024.10.017_bib0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/09638280600925860","article-title":"The effect of spasticity, sense and walking aids in falls of people after chronic stroke","volume":"29","author":"Soyuer","year":"2007","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.apmr.2024.10.017_bib0006","series-title":"Assessment of lower limb spasticity and other consequences of the upper motor neuron syndrome. In: Spasticity, Diagnosis and Management","first-page":"91","author":"Esquenazi","year":"2016"},{"key":"10.1016\/j.apmr.2024.10.017_bib0007","article-title":"Spasticity in adults: management using botulinum toxin","year":"2018","journal-title":"National guidelines"},{"key":"10.1016\/j.apmr.2024.10.017_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2024.10.017_bib0009","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxicon.2012.11.025","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome","volume":"67","author":"Esquenazi","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.apmr.2024.10.017_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp.61.3.265","article-title":"A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients","volume":"61","author":"Burbaud","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2024.10.017_bib0011","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.0000000000004687","article-title":"Efficacy and safety of abobotulinumtoxinA in spastic lower limb: randomized trial and extension","volume":"89","author":"Gracies","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2024.10.017_bib0012","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000069495","article-title":"A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke","volume":"15","author":"Pittock","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.apmr.2024.10.017_bib0013","doi-asserted-by":"crossref","first-page":"605","DOI":"10.23736\/S1973-9087.17.04808-0","article-title":"A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework","volume":"54","author":"Turner-Stokes","year":"2018","journal-title":"Eur J Phys Rehabil Med"},{"key":"10.1016\/j.apmr.2024.10.017_bib0014","doi-asserted-by":"crossref","first-page":"jrm00157","DOI":"10.2340\/16501977-2801","article-title":"Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study","volume":"53","author":"Turner-Stokes","year":"2021","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2024.10.017_bib0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2340\/16501977-1817","article-title":"Functional goal achievement in post-stroke spasticity patients: the BOTOX\u00ae Economic Spasticity Trial (BEST)","volume":"46","author":"Ward","year":"2014","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2024.10.017_bib0016","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1212\/WNL.0000000000003789","article-title":"Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: the TOWER study","volume":"88","author":"Wissel","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2024.10.017_bib0017","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1080\/09638288.2018.1451927","article-title":"Categorisation of goals set using goal attainment scaling for treatment of leg spasticity: a multicentre analysis","volume":"41","author":"Ashford","year":"2019","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.apmr.2024.10.017_bib0018","doi-asserted-by":"crossref","first-page":"jrm4257","DOI":"10.2340\/jrm.v55.4257","article-title":"Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study","volume":"55","author":"Esquenazi","year":"2023","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2024.10.017_bib0019","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","article-title":"Interrater reliability of a modified Ashworth scale of muscle spasticity","volume":"67","author":"Bohannon","year":"1987","journal-title":"Phys Ther"},{"key":"10.1016\/j.apmr.2024.10.017_bib0020","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1080\/09638288.2019.1643933","article-title":"Psychometric evaluation of the leg activity measure (LegA) for outcome measurement in people with brain injury and spasticity","volume":"43","author":"Ashford","year":"2021","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.apmr.2024.10.017_bib0021","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7861\/clinmedicine.8-4-393","article-title":"Screening for pain in patients with cognitive and communication difficulties: evaluation of the SPIN-screen","volume":"8","author":"Turner-Stokes","year":"2008","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.apmr.2024.10.017_bib0022","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0003-9993(96)90014-3","article-title":"Clinical assessment of spasticity in spinal cord injury: a multidimensional problem","volume":"77","author":"Priebe","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2024.10.017_bib0023","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/0269215508101742","article-title":"Goal attainment scaling (GAS) in rehabilitation: a practical guide","volume":"23","author":"Turner-Stokes","year":"2009","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2024.10.017_bib0024","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF01530764","article-title":"Goal attainment scaling: a general method for evaluating comprehensive community mental health programs","volume":"4","author":"Kiresuk","year":"1968","journal-title":"Community Ment Health J"},{"key":"10.1016\/j.apmr.2024.10.017_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/pri.36","article-title":"Goal attainment for spasticity management using botulinum toxin","volume":"11","author":"Ashford","year":"2006","journal-title":"Physiother Res Int"},{"key":"10.1016\/j.apmr.2024.10.017_bib0026","first-page":"83","article-title":"Goal attainment with integrated upper limb spasticity management including botulinum toxin-A (BoNT-A): subanalysis of Australian data from the ULIS-III study","volume":"6","author":"Luk","year":"2023","journal-title":"J Int Soc Phys Rehabil Med"},{"key":"10.1016\/j.apmr.2024.10.017_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/toxins16010019","article-title":"Improvement in quality-of-life-related outcomes following treatment with incobotulinumtoxinA in adults with limb spasticity: a pooled analysis","volume":"16","author":"Molteni","year":"2023","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.apmr.2024.10.017_bib0028","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3390\/toxins10120535","article-title":"AbobotulinumtoxinA (Dysport\u00ae), OnabotulinumtoxinA (Botox\u00ae), and IncobotulinumtoxinA (Xeomin\u00ae) neurotoxin content and potential implications for duration of response in patients","volume":"10","author":"Field","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.apmr.2024.10.017_bib0029","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.pmrj.2014.09.021","article-title":"Botulinum toxin injection techniques for the management of adult spasticity","volume":"7","author":"Walker","year":"2015","journal-title":"PM R"},{"key":"10.1016\/j.apmr.2024.10.017_bib0030","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/0269215513497735","article-title":"Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques","volume":"28","author":"Picelli","year":"2014","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2024.10.017_bib0031","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.apmr.2007.10.022","article-title":"Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia","volume":"89","author":"Mayer","year":"2008","journal-title":"Arch Phys Med Rehabil"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999324013480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999324013480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:21:50Z","timestamp":1762089710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999324013480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0003999324013480"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2024.10.017","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2024.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}